MercoPress, en Español
Montevideo, September 30th 2026 - 13:58 UTC
Brazil's National Health Surveillance Agency (Anvisa) has received a request for the emergency use of Pfizer's newest vaccine against COVID-19 which would be active against both the original and the Ômicron strain, subvariant BA.1.
Get our news on your inbox! Suscribe